ROBERT HEIM: Open Payments
NPI 1013248509 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 12 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $20 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $35 |
| PFIZER INC. | 2 | $35 |
| Dexcom, Inc. | 1 | $30 |
| Braintree Laboratories, Inc. | 1 | $26 |
| Abbott Laboratories | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 2 | $16 |
Products named: Veozah, PREVNAR 20, Dexcom G6 Transmitter, SUTAB, FREESTYLE LIBRE 3, UBRELVY, MOUNJARO, SHINGRIX.
Industry payments across NC — which companies pay providers there.
